A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Y. Reuben, MD
Medical University of South Carolina Hollings Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Arizona Cancer Center
Tucson, Arizona, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Emory University
Atlanta, Georgia, United States
- University of Iowa Hospitals & Clinics
Iowa City, Iowa, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Washington University at St. Louis
St Louis, Missouri, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Sept 2012
- Primary completion
- 24 Apr 2019
- Completion
- 24 Apr 2019
- Last update posted
- 6 Apr 2020
- Registered enrollment
- 90
- Registry id
- NCT01593748
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.